ArisGlobal, a provider of solutions to the life sciences industry, announced the agCenter? 3.1, a clinical research investigator site portal that facilitates and streamlines the communication and collaboration between sponsors and their clinical study sites.
ArisGlobal, a provider of solutions to the life sciences industry, announced the agCenter™ 3.1, a clinical research investigator site portal that facilitates and streamlines the communication and collaboration between sponsors and their clinical study sites. agCenter addresses a key challenge that sponsors face in how to best retain and recruit investigators who often experience difficulties in meeting their study obligations. The investigator portal is the newest addition to ArisGlobal’s Total Clinical™, a comprehensive platform for clinical research that includes EDC, CTMS, ePRO, medical coding, trial disclosure, supply chain management and safety reporting -- all accessed via agWorld™, a central clinical portal.
“Finding and engaging with clinical study sites is becoming increasingly challenging labor-intensive and expensive, especially with today’s complex, global trials,” commented Simon Sparkes, senior vice president and head of the Clinical and Compliance business units at ArisGlobal. “As a result, all Sponsors are looking for ways to improve site relationships while containing costs. As EDC reaches almost full adoption, Sponsors now recognize that investigator portals represent an important step forward in improving site relationships, reducing site start-up times and also reducing the high cost of site management.”
From its intuitive dashboard, agCenter offers the full range of functionality to meet the needs of both sponsors and investigators:
agCenter 3.1 will be delivered to customers as a cloud-based solution via agOnDemand™, ArisGlobal's highly proven Software-as-a-Service (SaaS) delivery platform.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.